Haifa Kathrin Al-Ali

Papers authored by Haifa Kathrin Al-Ali

This paper is made freely available by the publisher.

2015 N. Jaekel, K. Lieder, S. Albrecht, O. Leismann, K. Hubert, G. Bug, N. Kröger, U. Platzbecker

, M. U. Muckenthaler, D. Niederwieser, H. K. Al-Ali

Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation

Download from www.nature.com

This paper was not found in any repository, but could be made available legally by the author.

Anne Koehler, Karolin Hubert, Thoralf Lange, Udo Siebolts, Claudia Wickenhauser, Prashanth Gopalakrishna, Dietger Niederwieser, Astrid Monecke, Haifa Kathrin Al-Ali

JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib

Upload

Hervé Dombret, John F. Seymour, Aleksandra Butrym, Agnieszka Wierzbowska

, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James Cavenagh, Andre C. Schuh, Anna Candoni, Christian Récher, Irwindeep Sandhu, Teresa Bernal del Castillo, Haifa Kathrin Al-Ali

, Giovanni Martinelli and 10 other authors

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Download from ashpublications.org

A. Rockstroh, H. K. Al-Ali

, T. Lange, W. Pönisch, R. Krahl, M. Cross, G. Behre, D. Niederwieser, C. Pfrepper

Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation

Upload

Song-Yau Wang, Thomas Ebert, Nadja Jaekel, Stefan Schubert, Dietger Niederwieser, Haifa Kathrin Al-Ali

Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia

Upload

This paper is available in a repository.

2014 Haifa Kathrin Al-Ali

, Nadja Jaekel, Dietger Niederwieser

The role of hypomethylating agents in the treatment of elderly patients with AML

Download from www.researchgate.net

2013 N. Jaekel, G. Behre, A. Behning, C. Wickenhauser, T. Lange, D. Niederwieser, H. K. Al-Ali

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

Download from www.nature.com

U. Platzbecker

, H. K. Al-Ali

, N. Gattermann, D. Haase, V. Janzen, J. Krauter, K. Goetze, K. Gotze, R. Schlenk, F. Nolte, A. Letsch, Oliver G. Ottmann, A. Kuendgen, A. Kündgen, M. Luebbert and 9 other authors

Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients

Download from www.nature.com

Wolfram Pönisch, Barbara Moll, Malvina Bourgeois, Marc Andrea, Thomas Schliwa, Simone Heyn, Marion Schmalfeld, Thomas Edelmann, Cornelia Becker, Franz Albert Hoffmann, Andreas Schwarzer, Ute Kreibich, Matthias Egert, Runa Stiegler, Rainer Krahl and 9 other authors

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure

Download from link.springer.com

Ruben A. Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, Haifa Kathrin Al-Ali

, Jason R. Gotlib, Heinz Gisslinger, Richard S. Levy, Andres Siulnik, Vikas Gupta

, Mahmudul Khan, John F. DiPersio, Mari McQuitty, John V. Catalano, Deborah S. Hunter, Laurent Knoops and 20 other authors

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

Download from dx.doi.org

Michael Cross, Haifa Kathrin Al-Ali

, Enrica Bach, Rainer Krahl, Nadja Jaekel, Dietger Niederwieser, Christian Junghanss, Thao Tran, Georg Maschmeyer

Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia

Download from dx.doi.org

Wolfram Pönisch, Simone Heyn, Juliane Beck, Ina Wagner, Martin Mohren, Franz A. Hoffmann, Thoralf Lange, Marion Schmalfeld, Thomas Zehrfeld, Andreas Schwarzer, Cornelia Winkelmann, Thomas Edelmann, Ramona Röhrborn, Karin Hebenstreit, Haifa K. Al-Ali

and 2 other authors

Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077

Upload

Francisco Cervantes, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali

, Andres Sirulnik, Viktoriya Stalbovskaya, Mari McQuitty, Deborah S. Hunter, Richard S. Levy, Francesco Passamonti, Tiziano Barbui, Giovanni Barosi, Claire N. Harrison, Laurent Knoops, Heinz Gisslinger

Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis.

Download from flore.unifi.it

2012 Wolfram Pönisch, Wolfram Poenisch, Malvina Bourgeois, Barbara Moll, Simone Heyn, Nadja Jäkel, Ina Wagner, Robert Rohrberg, Hans-Jürgen Hurtz, Marion Schmalfeld, Michael Aßmann, Thomas Edelmann, Martin Mohren, Franz-Albert Hoffmann, Cornelia Becker and 10 other authors

Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma

Download from doi.org

Enrica Bach, Rainer Krahl, Thoralf Lange, Frank Schüler, Haifa Al-Ali

, Thomas Büchner, Torsten Haferlach, Gottfried Dölken, Dietger Niederwieser, Michael Cross

Delayed processing of bone marrow samples reveals a prognostic pattern ofNMEmRNA expression in cytogenetically normal acute myeloid leukemia

Upload

Sabine Tschiedel, Enrica Bach, Annette Jilo, Song-Yau Wang, Thoralf Lange, Haifa-Kathrin Al-Ali

, Vladan Vucinic, Dietger Niederwieser, Michael Cross

Bcr–Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia

Upload

A. Giagounidis, H. Al-Ali

, A. Mohr, D. Haase, W. Hofmann, K. Kreuzer, N. Gattermann

Eisenchelat-Therapie mit Deferasirox: Therapiebeginn und Dosisoptimierung

Upload

Claire Harrison, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali

, Heinz Gisslinger, Roger Waltzman, Viktoriya Stalbovskaya, Mari McQuitty, Deborah S. Hunter, Richard Levy, Laurent Knoops, Francisco Cervantes, Alessandro M. Vannucchi, Tiziano Barbui, Giovanni Barosi

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

Download from www.researchgate.net

2011 T. Kiefer, C. Hirt, C. Späth, F. Schüler, H. K. Al Ali

, H.-H. Wolf, R. Herbst, G. Maschmeyer, K. Helke, C. Kessler, D. Niederwieser, C. Busemann, H. Schroeder, S. Vogelgesang, M. Kirsch and 3 other authors

Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study

Download from academic.oup.com